$1.57 Billion is the total value of Eversept Partners, LP's 107 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 52.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| QQQ | New | INVESCO QQQ TRput | $114,023,810 | – | 286,600 | +100.0% | 7.28% | – |
| HZNP | Buy | HORIZON THERAPEUTICS PUB L | $89,844,900 | +29.2% | 833,750 | +31.4% | 5.74% | +18.9% |
| CYH | Buy | COMMUNITY HEALTH SYS INC NEW | $85,044,751 | +21.4% | 6,389,538 | +6.7% | 5.43% | +11.7% |
| UTHR | Sell | UNITED THERAPEUTICS CORP DEL | $84,686,074 | +3.2% | 391,920 | -11.8% | 5.41% | -5.0% |
| GSK | GLAXOSMITHKLINE PLCcall | $66,313,170 | +15.4% | 1,503,700 | 0.0% | 4.24% | +6.2% | |
| DHR | Buy | DANAHER CORPORATION | $55,983,620 | +24.2% | 170,053 | +14.9% | 3.58% | +14.3% |
| AZN | Buy | ASTRAZENECA PLCsponsored adr | $55,292,298 | +3.3% | 949,224 | +6.6% | 3.53% | -4.9% |
| ASND | Sell | ASCENDIS PHARMA A/Ssponsored adr | $54,306,801 | -23.5% | 403,678 | -9.3% | 3.47% | -29.6% |
| AVTR | Sell | AVANTOR INC | $47,427,095 | -10.2% | 1,125,465 | -12.9% | 3.03% | -17.4% |
| BHVN | New | BIOHAVEN PHARMACTL HLDG CO L | $43,427,927 | – | 315,129 | +100.0% | 2.77% | – |
| ARKG | Sell | ARK ETF TRgenomic rev etf | $40,693,000 | -21.0% | 664,484 | -3.6% | 2.60% | -27.3% |
| NVST | Buy | ENVISTA HOLDINGS CORPORATION | $38,269,368 | +12.9% | 849,298 | +4.7% | 2.44% | +3.9% |
| AMRN | Sell | AMARIN CORP PLCspons adr new | $35,632,028 | -39.8% | 10,573,302 | -8.9% | 2.28% | -44.6% |
| MCK | Sell | MCKESSON CORP | $33,898,274 | +5.0% | 136,111 | -15.8% | 2.17% | -3.3% |
| AZN | Buy | ASTRAZENECA PLCcall | $33,336,475 | +113.2% | 572,300 | +119.9% | 2.13% | +96.3% |
| AMRX | Sell | AMNEAL PHARMACEUTICALS INC | $30,850,340 | -15.7% | 6,440,572 | -6.0% | 1.97% | -22.4% |
| IWM | New | ISHARES TRput | $27,806,250 | – | 125,000 | +100.0% | 1.78% | – |
| IWO | New | ISHARES TRput | $26,374,500 | – | 90,000 | +100.0% | 1.68% | – |
| GSK | Buy | GLAXOSMITHKLINE PLCsponsored adr | $25,039,082 | +62.5% | 567,205 | +41.2% | 1.60% | +49.5% |
| CLDX | New | CELLDEX THERAPEUTICS INC NEW | $22,893,350 | – | 592,478 | +100.0% | 1.46% | – |
| VRTX | Sell | VERTEX PHARMACEUTICALS INCcall | $20,664,360 | -34.3% | 94,100 | -45.7% | 1.32% | -39.5% |
| OCDX | Sell | ORTHO CLINICAL DIAGNOSTICS H | $18,954,535 | +12.1% | 886,140 | -3.2% | 1.21% | +3.2% |
| RCM | Sell | R1 RCM INC | $18,687,535 | +11.0% | 733,132 | -4.1% | 1.19% | +2.1% |
| CNC | Buy | CENTENE CORP DEL | $18,508,111 | +110.5% | 224,613 | +59.2% | 1.18% | +93.8% |
| TEVA | Sell | TEVA PHARMACEUTICAL INDS LTDsponsored ads | $18,434,999 | -46.8% | 2,301,498 | -35.3% | 1.18% | -51.0% |
| CYH | Buy | COMMUNITY HEALTH SYS INC NEWcall | $16,999,532 | +34.9% | 1,277,200 | +18.6% | 1.09% | +24.1% |
| ICLR | Sell | ICON PLC | $16,063,210 | -14.7% | 51,867 | -27.9% | 1.03% | -21.6% |
| ANTM | Buy | ANTHEM INC | $15,896,641 | +34.8% | 34,294 | +8.4% | 1.02% | +24.1% |
| ARKG | New | ARK ETF TRcall | $14,930,312 | – | 243,800 | +100.0% | 0.95% | – |
| FATE | Sell | FATE THERAPEUTICS INC | $14,907,763 | -3.6% | 254,790 | -2.3% | 0.95% | -11.3% |
| HQY | Buy | HEALTHEQUITY INC | $14,747,492 | +99.1% | 333,352 | +191.4% | 0.94% | +83.3% |
| LH | Sell | LABORATORY CORP AMER HLDGS | $14,303,468 | -60.4% | 45,522 | -64.5% | 0.91% | -63.5% |
| XBI | New | SPDR SER TRcall | $12,741,048 | – | 113,800 | +100.0% | 0.81% | – |
| HUM | Buy | HUMANA INC | $12,719,675 | +35.5% | 27,382 | +13.7% | 0.81% | +24.7% |
| HCA | Buy | HCA HEALTHCARE INC | $12,613,230 | +35.4% | 49,094 | +28.0% | 0.81% | +24.8% |
| ITCI | Buy | INTRA-CELLULAR THERAPIES INC | $12,131,732 | +41.0% | 231,787 | +0.5% | 0.78% | +29.8% |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $11,911,299 | +6.5% | 70,240 | +18.6% | 0.76% | -1.9% |
| IONS | Sell | IONIS PHARMACEUTICALS INC | $11,709,129 | -22.5% | 384,789 | -14.6% | 0.75% | -28.7% |
| ARKK | Buy | ARK ETF TRinnovation etf | $11,267,372 | +191.3% | 119,118 | +240.3% | 0.72% | +167.7% |
| NSTG | Buy | NANOSTRING TECHNOLOGIES INC | $11,220,300 | +38.6% | 265,695 | +57.5% | 0.72% | +27.6% |
| GH | Sell | GUARDANT HEALTH INC | $10,035,407 | -20.0% | 100,334 | -0.0% | 0.64% | -26.4% |
| MGLN | MAGELLAN HEALTH INC | $9,945,453 | +0.5% | 104,700 | 0.0% | 0.64% | -7.6% | |
| EXEL | Buy | EXELIXIS INC | $9,792,596 | -10.3% | 535,700 | +3.8% | 0.63% | -17.4% |
| NTRA | Sell | NATERA INC | $9,532,411 | -23.8% | 102,071 | -9.0% | 0.61% | -29.8% |
| TARO | Buy | TARO PHARMACEUTICAL INDS LTD | $9,077,477 | -20.5% | 181,151 | +1.0% | 0.58% | -26.8% |
| QGEN | Buy | QIAGEN NV | $9,033,640 | +22.1% | 162,534 | +13.6% | 0.58% | +12.5% |
| ZGNX | Sell | ZOGENIX INC | $8,953,198 | -23.9% | 550,966 | -28.9% | 0.57% | -30.0% |
| SYNH | New | SYNEOS HEALTH INCcl a | $8,790,640 | – | 85,612 | +100.0% | 0.56% | – |
| IRTC | Sell | IRHYTHM TECHNOLOGIES INC | $8,611,260 | +29.2% | 73,169 | -35.7% | 0.55% | +18.8% |
| PODD | New | INSULET CORP | $8,027,864 | – | 30,172 | +100.0% | 0.51% | – |
| BIIB | New | BIOGEN INC | $7,927,197 | – | 33,041 | +100.0% | 0.51% | – |
| TEVA | TEVA PHARMACEUTICAL INDS LTDcall | $7,708,824 | -17.8% | 962,400 | 0.0% | 0.49% | -24.4% | |
| HZNP | HORIZON THERAPEUTICS PUB Lcall | $7,543,200 | -1.6% | 70,000 | 0.0% | 0.48% | -9.4% | |
| ARGX | Buy | ARGENX SEsponsored adr | $7,527,684 | +333.8% | 21,496 | +274.1% | 0.48% | +300.8% |
| CERN | New | CERNER CORP | $7,221,692 | – | 77,543 | +100.0% | 0.46% | – |
| LQDA | Buy | LIQUIDIA CORPORATION | $7,051,263 | +175.0% | 1,447,898 | +55.8% | 0.45% | +152.8% |
| IQV | Buy | IQVIA HLDGS INC | $6,945,723 | +327.0% | 24,618 | +262.6% | 0.44% | +292.9% |
| XENE | New | XENON PHARMACEUTICALS INC | $6,545,374 | – | 209,519 | +100.0% | 0.42% | – |
| ANAB | Buy | ANAPTYSBIO INC | $6,345,767 | +199.8% | 182,612 | +134.0% | 0.40% | +175.5% |
| PKI | Sell | PERKINELMER INC | $6,206,521 | -23.9% | 30,869 | -34.4% | 0.40% | -30.0% |
| SIBN | Buy | SI-BONE INC | $5,732,268 | +78.4% | 258,094 | +72.1% | 0.37% | +64.1% |
| NVRO | New | NEVRO CORP | $5,356,619 | – | 66,074 | +100.0% | 0.34% | – |
| ZNTL | New | ZENTALIS PHARMACEUTICALS INC | $5,309,482 | – | 63,163 | +100.0% | 0.34% | – |
| MRK | New | MERCK & CO INC | $5,025,107 | – | 19,456 | +100.0% | 0.32% | – |
| AUPH | New | AURINIA PHARMACEUTICALS INC | $4,605,652 | – | 201,384 | +100.0% | 0.29% | – |
| VRDN | Buy | VIRIDIAN THERAPEUTICS INC | $3,847,025 | +46.2% | 194,589 | +21.6% | 0.25% | +34.4% |
| MRK | MERCK & CO INCcall | $3,732,368 | +2.0% | 48,700 | 0.0% | 0.24% | -6.3% | |
| MRVI | Sell | MARAVAI LIFESCIENCES HLDGS I | $3,678,611 | -77.1% | 87,795 | -73.2% | 0.24% | -79.0% |
| ISRG | Buy | INTUITIVE SURGICAL INC | $3,530,123 | +12.9% | 9,825 | +212.4% | 0.23% | +4.1% |
| DXCM | DEXCOM INC | $3,437,017 | -1.8% | 6,401 | 0.0% | 0.22% | -9.5% | |
| PBYI | Buy | PUMA BIOTECHNOLOGY INC | $3,398,410 | +21.8% | 1,117,898 | +180.9% | 0.22% | +11.9% |
| LXRX | Sell | LEXICON PHARMACEUTICALS INC | $3,142,914 | -25.1% | 797,694 | -8.6% | 0.20% | -30.9% |
| A | Buy | AGILENT TECHNOLOGIES INC | $3,102,159 | +5.5% | 19,431 | +4.1% | 0.20% | -2.9% |
| CVAC | New | CUREVAC N V | $2,916,933 | – | 85,017 | +100.0% | 0.19% | – |
| PGNY | New | PROGYNY INCput | $2,517,500 | – | 50,000 | +100.0% | 0.16% | – |
| GRTS | New | GRITSTONE BIO INC | $2,187,808 | – | 170,125 | +100.0% | 0.14% | – |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $2,176,880 | +31.5% | 14,840 | +58.6% | 0.14% | +20.9% |
| AUTL | Buy | AUTOLUS THERAPEUTICS PLCspon ads | $2,083,993 | -20.1% | 401,540 | +0.9% | 0.13% | -26.5% |
| KRTX | Sell | KARUNA THERAPEUTICS INC | $2,087,354 | -31.7% | 15,934 | -36.3% | 0.13% | -37.3% |
| ACAD | New | ACADIA PHARMACEUTICALS INCcall | $1,974,564 | – | 84,600 | +100.0% | 0.13% | – |
| SNY | Sell | SANOFIsponsored adr | $1,937,467 | -84.5% | 38,672 | -85.1% | 0.12% | -85.7% |
| ESTA | New | ESTABLISHMENT LABS HLDGS INC | $1,699,010 | – | 25,137 | +100.0% | 0.11% | – |
| UTHR | New | UNITED THERAPEUTICS CORP DELcall | $1,642,208 | – | 7,600 | +100.0% | 0.10% | – |
| SRGA | Sell | SURGALIGN HOLDINGS INC | $1,374,587 | -64.1% | 1,918,743 | -45.3% | 0.09% | -66.8% |
| ADAP | Sell | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $1,307,685 | -43.1% | 348,716 | -21.6% | 0.08% | -47.5% |
| RGEN | Buy | REPLIGEN CORP | $1,214,027 | -4.6% | 4,584 | +4.1% | 0.08% | -11.4% |
| AVRO | Sell | AVROBIO INC | $1,174,208 | -41.5% | 304,989 | -15.2% | 0.08% | -46.0% |
| MYO | MYOMO INC | $1,026,750 | -42.4% | 150,000 | 0.0% | 0.07% | -46.8% | |
| MIST | Buy | MILESTONE PHARMACEUTICALS IN | $963,931 | +48.6% | 147,165 | +29.6% | 0.06% | +37.8% |
| VCRA | New | VOCERA COMMUNICATIONS INC | $970,655 | – | 14,970 | +100.0% | 0.06% | – |
| ENSG | ENSIGN GROUP INC | $873,504 | +12.1% | 10,397 | 0.0% | 0.06% | +3.7% | |
| HSKA | HESKA CORP | $825,767 | -29.4% | 4,525 | 0.0% | 0.05% | -34.6% | |
| ACIU | Sell | AC IMMUNE SA | $759,231 | -49.0% | 153,380 | -30.8% | 0.05% | -52.4% |
| ASMB | Sell | ASSEMBLY BIOSCIENCES INC | $722,300 | -40.7% | 310,000 | -11.4% | 0.05% | -45.9% |
| LOGC | Sell | LOGICBIO THERAPEUTICS INC | $672,443 | -58.0% | 291,101 | -16.8% | 0.04% | -61.3% |
| CYCN | CYCLERION THERAPEUTICS INC | $639,763 | -44.0% | 371,955 | 0.0% | 0.04% | -48.1% | |
| MRUS | New | MERUS N V | $604,200 | – | 19,000 | +100.0% | 0.04% | – |
| ORTX | Sell | ORCHARD THERAPEUTICS PLCads | $553,847 | -57.7% | 419,581 | -26.3% | 0.04% | -61.5% |
| ELDN | ELEDON PHARMACEUTICALS INC | $502,775 | -28.6% | 114,008 | 0.0% | 0.03% | -34.7% | |
| GOSS | Sell | GOSSAMER BIO INC | $451,382 | -76.0% | 39,910 | -73.4% | 0.03% | -77.9% |
| CSU | New | SONIDA SENIOR LIVING INC | $433,304 | – | 15,209 | +100.0% | 0.03% | – |
| MREO | Sell | MEREO BIOPHARMA GROUP PLCads | $415,152 | -80.9% | 259,470 | -71.2% | 0.03% | -82.1% |
| BKD | New | BROOKDALE SR LIVING INC | $408,393 | – | 79,146 | +100.0% | 0.03% | – |
| JYNT | New | JOINT CORPput | $361,295 | – | 5,500 | +100.0% | 0.02% | – |
| FSTX | F-STAR THERAPEUTICS INC | $250,664 | -31.4% | 49,933 | 0.0% | 0.02% | -36.0% | |
| MNKD | New | MANNKIND CORPcall | $218,500 | – | 50,000 | +100.0% | 0.01% | – |
| GLYC | New | GLYCOMIMETICS INC | $144,000 | – | 100,000 | +100.0% | 0.01% | – |
| FREQ | Exit | FREQUENCY THERAPEUTICS INC | $0 | – | -30,000 | -100.0% | -0.02% | – |
| CCRN | Exit | CROSS CTRY HEALTHCARE INC | $0 | – | -20,000 | -100.0% | -0.03% | – |
| Exit | TELIGENT INC NEW | $0 | – | -1,069,465 | -100.0% | -0.03% | – | |
| FREQ | Exit | FREQUENCY THERAPEUTICS INCput | $0 | – | -67,900 | -100.0% | -0.03% | – |
| DCPH | Exit | DECIPHERA PHARMACEUTICALS INcall | $0 | – | -18,700 | -100.0% | -0.04% | – |
| PHAS | Exit | PHASEBIO PHARMACEUTICALS INC | $0 | – | -300,000 | -100.0% | -0.06% | – |
| AMN | Exit | AMN HEALTHCARE SVCS INC | $0 | – | -10,000 | -100.0% | -0.08% | – |
| AKYA | Exit | AKOYA BIOSCIENCES INC | $0 | – | -91,568 | -100.0% | -0.09% | – |
| MGTA | Exit | MAGENTA THERAPEUTICS INC | $0 | – | -198,879 | -100.0% | -0.10% | – |
| EDIT | Exit | EDITAS MEDICINE INCput | $0 | – | -50,000 | -100.0% | -0.14% | – |
| NVAX | Exit | NOVAVAX INCcall | $0 | – | -10,000 | -100.0% | -0.14% | – |
| HSTM | Exit | HEALTHSTREAM INC | $0 | – | -77,812 | -100.0% | -0.15% | – |
| OM | Exit | OUTSET MED INC | $0 | – | -47,500 | -100.0% | -0.16% | – |
| MORF | Exit | MORPHIC HLDG INC | $0 | – | -43,600 | -100.0% | -0.17% | – |
| EVH | Exit | EVOLENT HEALTH INCcl a | $0 | – | -100,170 | -100.0% | -0.22% | – |
| APLS | Exit | APELLIS PHARMACEUTICALS INCcall | $0 | – | -126,400 | -100.0% | -0.29% | – |
| HRC | Exit | HILL-ROM HLDGS INCcall | $0 | – | -29,400 | -100.0% | -0.31% | – |
| HRC | Exit | HILL-ROM HLDGS INC | $0 | – | -30,000 | -100.0% | -0.31% | – |
| GOCO | Exit | GOHEALTH INC | $0 | – | -1,261,723 | -100.0% | -0.44% | – |
| MASI | Exit | MASIMO CORP | $0 | – | -67,000 | -100.0% | -1.26% | – |
| CTLT | Exit | CATALENT INC | $0 | – | -184,299 | -100.0% | -1.70% | – |
| BMY | Exit | BRISTOL-MYERS SQUIBB CO | $0 | – | -464,801 | -100.0% | -1.93% | – |
| SPY | Exit | SPDR S&P 500 ETF TRput | $0 | – | -100,000 | -100.0% | -2.98% | – |
| XLRN | Exit | ACCELERON PHARMA INC | $0 | – | -349,494 | -100.0% | -4.18% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMARIN CORP PLC | 21 | Q3 2023 | 12.5% |
| DANAHER CORPORATION | 21 | Q3 2023 | 8.1% |
| AFFIMED N V | 20 | Q3 2023 | 0.9% |
| ARGENX SE | 19 | Q3 2023 | 2.0% |
| GSK PLC | 18 | Q2 2022 | 13.1% |
| ASCENDIS PHARMA A/S | 18 | Q1 2022 | 7.7% |
| SANOFI | 18 | Q4 2022 | 7.2% |
| ENSIGN GROUP INC | 18 | Q1 2022 | 8.6% |
| CENTENE CORP DEL | 18 | Q3 2023 | 1.5% |
| ZOGENIX INC | 17 | Q4 2021 | 12.4% |
View Eversept Partners, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cabaletta Bio, Inc. | February 14, 2023 | 282,874 | 1.0% |
| Teligent, Inc.Sold out | February 16, 2021 | 0 | 0.0% |
| Teligent, Inc. | February 14, 2020 | 4,501,799 | 8.4% |
View Eversept Partners, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
View Eversept Partners, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.